Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Sona Nanotech Inc > Others are getting FDA Approval
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1010)
•••
Comment by shoosh22on Aug 27, 2020 8:13am
151 Views
Post# 31459241

RE:RE:RE:RE:RE:RE:Others are getting FDA Approval

RE:RE:RE:RE:RE:RE:Others are getting FDA Approval Beleive me I have been invested in Sona since Feb.. I have followed evey step of the way, and provided a lot of DD here.  So I'm very confident that Sona's Test is one of a kind right now, and the best Antigen test out there.. that is truly rapid and will also be used as a home test in the 2.0 version. 
 
MikeyH wrote: Thanks. I guess I'll just have to wait, if they haven't shared this data generally they won't share it with just me for sure.

But again, be careful with what you read and believe out there everyone. The asymptomatic claims seem to have just appeared from nowhere. If they are true, and I am wrong, I will happily hold my hands up and apologize. But keep asking the questions, yoiu have every right to as investors!


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities